Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oral formulations of pyrrolidine derivatives

Oral formulations of pyrrolidine derivatives

US Patent 9962367 · Granted May 8, 2018

Estimated economic value: $6,460,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine f2023
Compositions and methods for delaying the incidence of labor2022
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt 2022
Oral formulations of pyrrolidine derivatives2022
Oral formulations of pyrrolidine derivatives2022
Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonists2022
Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]2020
Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonists2020
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt 2020
Oral formulations of pyrrolidine derivatives2019
Oral formulations of pyrrolidine derivatives2019
Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists2018